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Beneﬁcial modulation of the gut microbiota
P. Cotter
Teagasc Food Research Centre and APC Microbiome
Institute, Cork, Ireland
Abstract: As the scientiﬁc community continues to develop an
ever-greater understanding of the composition and function of the
human gut microbiota, and the role of speciﬁc microbial popula-
tions in health and disease, attention has turned to the tools that
are at our disposal with respect to altering these microbes in a
beneﬁcial way. The options available include the use of diet, probi-
otics/prebiotics, antimicrobials and, potentially, exercise. Here, our
recent investigations of the relationship between protein, bacteri-
ocin producing probiotics and exercise and the gut microbiota and,
in turn, health will be described.
http://dx.doi.org/10.1016/j.ijid.2016.02.121
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Rotavirus vaccines - A promise kept
J.E. Tate
Centers for Disease Control and Prevention, Atlanta,
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Abstract: Vaccines are now available to combat rotavirus, the
most common cause of severe, dehydrating diarrhea among chil-
dren worldwide. As of January 2016, 80 countries have introduced
rotavirus vaccines into their routine immunization programs.
High and middle income countries were the early introducers of
rotavirus vaccines and in these countries, vaccines have reduced
all-cause diarrhea and rotavirus hospitalizations by 17%-55% and
49-92%, respectively, and all-cause diarrhea deaths by 22%-50%
in some settings. Additionally, indirect protection of children age-
ineligible for rotavirus vaccine has also been observed in some high
and middle-income countries. Rotavirus vaccine introductions in
low income countries have been increasing in recent years and
early data from these settings are promising. Vaccine effective-
ness is comparable to the efﬁcacy observed in clinical trials and
the impact in high disease burden settings has been dramatic. As
rotavirus vaccines continue to rollout in low income countries, the
full range of health beneﬁts in these settings can be documented.
http://dx.doi.org/10.1016/j.ijid.2016.02.122
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Norovirus infection and vaccine development:
Where are we?
M. O’Ryan
University of Chile, Santiago, Chile
Abstract: Noroviruses are currently recognized as the leading
cause of acute gastroenteritis outbreaks associated with contami-
nated food and/or water consumption in industrialized countries
and second to rotavirus as cause of childhood gastroenteritis. Indi-
viduals are infected many times throughout their lifetime, most of
which are asymptomatic infections with fewer episodes of mod-
erate to severely symptomatic infections which are particularly
signiﬁcant in young children living in resource-deprived countries.
Symptomatic norovirus infections are in general less severe than
rotavirus infections in children which do not preclude that severe
norovirus infections characterized by intense vomiting, watery
diarrhea and fever leading to shock and death occur worldwide.
Near 200.000 norovirus-associated deaths are estimated to occur
every year in children. Norovirus of the genogroup GII.4 have
largely predominated throughout the past years and prevention
may be possible through vaccination using virus-like particles. A
Phase I challenge study using an intramuscular bivalent GI.1/GII.4
vaccine in adults demonstrated signiﬁcant protection and Phase II
trials in children are planned for 2017.
http://dx.doi.org/10.1016/j.ijid.2016.02.123
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The outcomes of cryptosporidial infections in
Indian children
G. Kang
Christian Medical College, Vellore, India
Abstract: Cryptosporidium is an apicomplexan protozoan para-
site that has gained attention in the past two decades as a clinically
important human pathogen. The recent Global Enteric Multicen-
ter Study (GEMS) reported Cryptosporidium spp. as one of the four
top pathogens causing moderate to severe diarrhoea in children. In
India alone, we estimated cryptosporidiosis to cause 3.9 to 7.1 mil-
lion diarrhoeal episodes, 66.4 to 249 thousand hospitalizations and
5.8 to 14.6 thousand deaths in children under the age of two years.
A large proportion of children, especially those living in resource-
limited settings, are asymptomatically infected.
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The impact of cryptosporidiosis is not limited to the diarrhoeal
episode alone but has been associated with long term sequelae,
with several studies suggesting that both asymptomatic and symp-
tomatic cryptosporidial infections have a signiﬁcant adverse effect
on nutritional status, cognitive development, increased overall
diarrhoeal burden and mortality in children.
Although there are studies showinghigh cryptosporidial disease
burden in developing countries, resulting in immediate and pro-
longed morbidity, the epidemiology of cryptosporidial infections
in humans is not clearly understood. Moreover, there is a dearth
of longitudinal data on the course of infection in the absence of
overt diarrheal disease. A clear understanding of the natural history
of cryptosporidiosis and correlates of protection are essential in
developing effective, efﬁcient and sustainable disease control and
preventive measures. In intensive active surveillance of a cohort of
children frombirth till threeyearsof age to study thenaturalhistory
of cryptosporidiosis in a semi-urban slum area in southern India,
we have shown early childhood exposure and a high rate of asymp-
tomatic infection. The proportion of re-infected children was high
and clusteringwas observed in children for both infection and diar-
rhoea. Protection against cryptosporidial infection increased with
theorder of infectionbutwasonly69%after four infections.C. homi-
nis was the predominant Cryptosporidium species, and there was
no evidence of species-speciﬁc protection. Clustering of infection
is suggestive of host susceptibility.Multiple re-infections conferred
some degree of protection against subsequent infection.
These studies demonstrate the power of harnessing the syner-
gistic beneﬁts of a birth cohort study design in a community setting
and efﬁcient molecular approaches to detect cryptosporidial
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Molecular diagnostics and the aetiology of
diarrhea in low-income countries
J. Platts-Mills
Division of Infectious Diseases and International
Health, Charlottesville, VA, USA
Abstract: Studies of childhood diarrhea in developing countries
have traditionally employed a wide range of diagnostic modalities
including culture, microscopy, and enzyme immunoassay. Molec-
ular diagnostics offer a substantial increase in sensitivity, however
they also increase the background rate of pathogen detection. A
quantitative analytic approach can help identify the subset of clin-
ically signiﬁcant molecular detections. In this symposium talk, we
will present estimates of of pathogen-speciﬁc attributable fractions
of diarrhea from ongoing re-analyses of two multisite studies of
childhooddiarrhea (GEMSandMAL-ED). Compared to prior burden
estimates from these studies, this approach reveals a substantial
increase in the burden of diarrhea due to pathogens for which con-
ventional diagnostics were not sufﬁciently sensitive, in particular
Shigella, ST-ETEC, and adenovirus 40/41. Burden estimates for other
pathogens, including rotavirus and Cryptosporidium, were not sig-
niﬁcantly changed. After rotavirus, Shigellawas associatedwith the
highest burden of moderate-to-severe non-bloody diarrhea, which
suggests that current guidelines limiting the role of antibiotics
to bloody diarrhea in children in these settings need to be re-
evaluated. These ﬁndings also have signiﬁcant implications for the
prioritization of pathogen-speciﬁc interventions aimed at reducing
the burden of diarrheal disease in children in these settings.
http://dx.doi.org/10.1016/j.ijid.2016.02.125
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Dengue, Chikungunya and Zika Virus: Global
emergence
K.G. Luz
Hospital Giselda Trigueiro, Natal, Brazil
Abstract: (no abstract received from presenter)
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Pathogenesis of severe dengue infection
G.N. Malavige
University of Sri Jayawardenapura, Nugegoda, Sri
Lanka
Abstract: The pathogenesis of severe dengue (SD) is thought
to be due to the complex interplay between the virus, host genes
and the host immune response. As vascular leak, which is the hall
mark of SD, occurs following the resolution of the viraemia, it was
thought that an inappropriate immune response to the virus, was
the main cause of SD. However, recent data shows that dengue
NS1 alone activates monocytes through the TLR4 receptor, induc-
ing inﬂammatory cytokine production and that NS1 was involved
in vascular leak in acute dengue. We too have found that dengue
NS1 stimulates IL-10 production from monocytes, which in turn
could lead to suppression of dengue virus speciﬁc T cell responses
and thereby contribute to disease severity. In our studies, which
have investigated the kinetics of changes in inﬂammatory medi-
ators, the degree of viraemia and the onset and extent of vascular
leak, have shown that inﬂammatorymediators are signiﬁcantly ele-
vated in patients with SD, around day 4 to 5 of illness. Levels of
both IL-10 and IL-17 and other cytokines were signiﬁcantly ele-
vated in patients with SDwhen compared tomilder dengue, before
the onset of vascular leak.
